Literature DB >> 24742729

Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.

Vaughn Barry1, Lyndsey A Darrow2, Mitchel Klein2, Andrea Winquist2, Kyle Steenland2.   

Abstract

BACKGROUND: Infants and young children may be susceptible to developmental effects of perfluorooctanoic acid (PFOA) exposure. Two previous studies, one that examined a general population exposed to environmental PFOA levels and one conducted in mice exposed to experimental PFOA levels, found that early life exposure was associated with higher body mass index (BMI) in adulthood and effects may be stronger in women than in men.
OBJECTIVES: Examine whether elevated early life PFOA exposure was associated with adult BMI among a group of mid-Ohio valley residents exposed to a wide range of early life PFOA levels due to emissions from a chemical plant.
METHODS: The cohort consisted of 8764 adults aged 20-40 years who reported height and weight on a survey between 2008 and 2011. Annual retrospective early life PFOA serum concentrations were estimated for each participant based on residential history and nearby chemical plant emissions as well as background exposure not originating from the facility. We defined early life exposure as the estimated average PFOA serum concentration over the first three years of life. We examined the association between early life PFOA exposure and adult overweight (BMI ≥ 25 kg/m(2)) and obesity (BMI ≥ 30 kg/m(2)) risk using logistic and linear regression models.
RESULTS: Nearly half the participants (45%) had early life PFOA exposure serum concentration estimates above background levels. Using participants who were exposed only to background PFOA levels as the referent category with quintiles of exposure above background, adjusted odds ratios (and 95% confidence intervals) for overweight risk by increasing exposure category for women were 1.0 (ref), 1.0 (0.8, 1.3), 1.0 (0.8, 1.2), 1.0 (0.8, 1.2), 0.9 (0.7, 1.1), and 0.9 (0.7, 1.1) and for men were 1.0 (ref), 0.9 (0.6, 1.1), 1.0 (0.7, 1.3), 1.0 (0.8, 1.4), 0.7 (0.5, 0.9), and 0.9 (0.7, 1.1). Odds ratios for adult obesity risk were similar. Regression coefficients from linear models using BMI as a continuous outcome showed no association between early life PFOA exposure and adult BMI.
CONCLUSIONS: Elevated levels of PFOA exposure in early life were not associated with overweight and obesity risk in adulthood and results did not vary by sex.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMI; C8; Obesity; PFOA; Perfluorooctanoic acid

Mesh:

Substances:

Year:  2014        PMID: 24742729     DOI: 10.1016/j.envres.2014.03.025

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  24 in total

Review 1.  Infectious and Environmental Influences on the Obesity Epidemic.

Authors:  Lili Huo; Jasmine Lyons; Dianna J Magliano
Journal:  Curr Obes Rep       Date:  2016-09

Review 2.  Biomarkers linking PCB exposure and obesity.

Authors:  Somiranjan Ghosh; Lubica Murinova; Tomas Trnovec; Christopher A Loffredo; Kareem Washington; Partha S Mitra; Sisir K Dutta
Journal:  Curr Pharm Biotechnol       Date:  2014       Impact factor: 2.837

3.  Early-life exposures to persistent organic pollutants in relation to overweight in preschool children.

Authors:  Martina Karlsen; Philippe Grandjean; Pal Weihe; Ulrike Steuerwald; Youssef Oulhote; Damaskini Valvi
Journal:  Reprod Toxicol       Date:  2016-08-03       Impact factor: 3.143

Review 4.  Endocrine disruptors and obesity.

Authors:  Jerrold J Heindel; Retha Newbold; Thaddeus T Schug
Journal:  Nat Rev Endocrinol       Date:  2015-09-22       Impact factor: 43.330

Review 5.  Early-life exposure to EDCs: role in childhood obesity and neurodevelopment.

Authors:  Joseph M Braun
Journal:  Nat Rev Endocrinol       Date:  2016-11-18       Impact factor: 43.330

6.  Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.

Authors:  Juliette Legler; Tony Fletcher; Eva Govarts; Miquel Porta; Bruce Blumberg; Jerrold J Heindel; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2015-03-05       Impact factor: 5.958

Review 7.  Endocrine-disrupting chemicals: implications for human health.

Authors:  Linda G Kahn; Claire Philippat; Shoji F Nakayama; Rémy Slama; Leonardo Trasande
Journal:  Lancet Diabetes Endocrinol       Date:  2020-08       Impact factor: 32.069

8.  Perfluorooctanoate and changes in anthropometric parameters with age in young girls in the Greater Cincinnati and San Francisco Bay Area.

Authors:  S M Pinney; G C Windham; C Xie; R L Herrick; A M Calafat; K McWhorter; C S Fassler; R A Hiatt; L H Kushi; F M Biro
Journal:  Int J Hyg Environ Health       Date:  2019-07-09       Impact factor: 5.840

9.  Complex relationships between perfluorooctanoate, body mass index, insulin resistance and serum lipids in young girls.

Authors:  Cecily S Fassler; Sara E Pinney; Changchun Xie; Frank M Biro; Susan M Pinney
Journal:  Environ Res       Date:  2019-06-26       Impact factor: 6.498

10.  Environmental Factors Involved in Maternal Morbidity and Mortality.

Authors:  Abee L Boyles; Brandiese E Beverly; Suzanne E Fenton; Chandra L Jackson; Anne Marie Z Jukic; Vicki L Sutherland; Donna D Baird; Gwen W Collman; Darlene Dixon; Kelly K Ferguson; Janet E Hall; Elizabeth M Martin; Thaddeus T Schug; Alexandra J White; Kelly J Chandler
Journal:  J Womens Health (Larchmt)       Date:  2020-11-18       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.